Patent · US Expired

Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors

US6465508B1 · kind B1 · utility

2Cited by
3References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 23, 2001
Grant dateOct 15, 2002
Priority date
Expiry dateFeb 23, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/52
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Ortho-sulfonamido aryl hydroxamic acids are provided which are useful, inter alia, for the inhibition of matrix metalloproteinases and the treatment of conditions associated with overexpression of MMPs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.